Some peptides are named for a function, and the name then outlives the evidence. Delta sleep-inducing peptide (DSIP) is the clearest example in the literature. This profile explains what was actually reported in 1977, what later work did and did not confirm, and what that means for a lab choosing how to cite it.
What DSIP Is
DSIP is a nonapeptide: nine residues. Schoenenberger and Monnier reported its sequence in 1977 as Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu.
| Property | Value |
|---|---|
| Sequence | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu |
| Length | 9 residues |
| Approximate mass | about 849 Da (our calculation from the sequence) |
| First reported | 1977, from rabbit cerebral venous blood |
What Was Reported in 1977
The 1977 paper described a peptide isolated from rabbits and tested by infusing synthetic versions directly into the brain ventricles of rabbits, under double-blind conditions, with 58 animals including controls. Five possible metabolic fragments, two nonapeptide analogs and a related tripeptide were synthesized for comparison. The authors reported that only the synthetic parent peptide produced a specific enhancement of slow-wave and spindle patterns in the recordings.
That is the origin of the name. It describes the observation in a particular animal model with a particular route of delivery, not a general property of the molecule.
What Came After
In 2006, Kovalzon and Strekalova reviewed the field under a title that sums up the problem: "a still unresolved riddle". Their summary points are useful for any reader:
- The link between DSIP and sleep was never characterized further, in part because the gene, the protein precursor and a receptor were never isolated.
- DSIP's structure is unlike any known peptide family.
- Their own early work found that certain artificial analogs promoted slow-wave sleep in rabbits and rats, but not DSIP itself.
- They proposed that a different, DSIP-like peptide might account for the immunoreactivity and activity people had reported.
A separate result from 1993 shows how the naming problem can trap a reader. Sillard and colleagues, working with porcine brain, purified a 77-residue peptide that an antiserum raised against synthetic DSIP recognized. They named it DIP (DSIP-immunoreactive peptide). Its amino acid sequence was not related to DSIP's, and they suggested its function was probably related to transcription regulation. In other words, an antibody to DSIP could be recognizing something else entirely.
Why This Matters for Readers
- Check the claim, not the name. A name that states an effect is a hypothesis from the lab that coined it.
- Check the detection method. A result that relies on an antibody or antiserum is only as specific as the antibody. The 1993 paper is a documented case where it was not.
- Check the model. The original data come from rabbits with infusion into the brain. See Dish, Mouse or Human? Reading the Model Behind a Peptide Study.
- Check the sequence you are citing. Several analogs have been tested, so a paper's DSIP may not be the nonapeptide above.
If You Source This Compound for Research
- Ask for an analytical report with the lot number and mass that matches the nine-residue sequence.
- Check HPLC purity. A nine-residue acidic peptide is polar and may elute early, so read the chromatogram, not only the percentage.
- Store lyophilized material cold, dry and away from light. See Storing Lyophilized Peptides in the Lab and How to Read a Peptide Analytical Report.
FAQ
Is DSIP a hormone? The literature has not established that. The 2006 review says its natural occurrence and biological activity remain unclear.
Is DIP a larger form of DSIP? No. The 77-residue DIP described in 1993 is unrelated in sequence. It was found because an antiserum recognized it.
What does "peptide named for an effect" mean for citations? Cite what was measured, in which system, instead of repeating the name's implied function.
Sources
- Schoenenberger GA, Monnier M. Proceedings of the National Academy of Sciences, 1977. PubMed 265572: https://pubmed.ncbi.nlm.nih.gov/265572/
- Sillard R et al. European Journal of Biochemistry, 1993. PubMed 8375381: https://pubmed.ncbi.nlm.nih.gov/8375381/
- Kovalzon VM, Strekalova TV. Journal of Neurochemistry, 2006. PubMed 16539679: https://pubmed.ncbi.nlm.nih.gov/16539679/
Every Peptide Privé batch is tested by an independent lab.
Contact our team with documentation questions.
For in-vitro laboratory research only. Not for human or animal use.
